Industry: Chemical & Material
Published Date: 2025-10-22
Pages: 169 Pages
Report ld: 5200678
Request Sample
Customized Report
Biological Nematicides Market Size(US$)

CAGR 2025-2031
7.9%
Market Size,2031
USD 3,751
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Biological Nematicides market is projected to grow from US$ 2219 million in 2024 to US$ 3751 million by 2031, at a CAGR of 7.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
The global biological nematicides market has been witnessing significant growth and attention due to increasing concerns about environmentally friendly agricultural practices and the rising demand for organic and sustainable food production. The market for biological nematicides encompasses various regions and is influenced by several key factors:
Market Growth: The global biological nematicides market has been experiencing steady growth driven by a shift towards environmentally sustainable agricultural practices and an increasing focus on integrated pest management (IPM) strategies. Consumers’ growing preference for organic and chemical-free produce has also contributed to the expansion of the market.
Regional Dynamics: Different regions across the globe demonstrate varying levels of adoption and demand for biological nematicides. Regions such as North America, Europe, and Asia-Pacific are among the major contributors to the market, with factors such as regulatory support for bio-based products, increasing awareness about sustainable agriculture, and growing investments in research and development influencing market dynamics.
Product Innovation and Development: Ongoing research and development efforts in the field of biological nematicides have led to the introduction of new and advanced products with enhanced efficacy, safety, and application convenience. This continuous innovation is bolstering market growth and expanding the range of available biological nematicide solutions.
Agricultural Practices and Regulations: Evolving agricultural practices and regulatory frameworks play a critical role in shaping the demand for biological nematicides. Policies promoting sustainable agriculture, restrictions on the use of synthetic chemical pesticides, and certification requirements for organic farming are influencing the adoption of bio-based nematicides.
Market Players and Competition: The global biological nematicides market is characterized by the presence of numerous companies and research institutions engaged in the development, production, and commercialization of biological nematicide products. Competition among market players is driving further innovation and diversification of product offerings.
Market Challenges: Despite the positive growth trends, the biological nematicides market also faces challenges such as limited awareness among growers, potential performance variations under different environmental conditions, and the need for continued education and technical support for effective application.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Biological Nematicides market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Biological Nematicides study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Biological Nematicides: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Biological Nematicides Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Microbial-based Nematicides
1.2.3 Botanical Nematicides
1.2.4 Biocontrol Agents
1.2.5 Biostimulants
1.2.6 Biofumigants
1.2.7 Others
1.3 Market Segmentation by Application
1.3.1 Global Biological Nematicides Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Agriculture
1.3.3 Horticulture
1.3.4 Turf Management
1.3.5 Seed Treatment
1.3.6 Land Reclamation and Restoration
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biological Nematicides Revenue Estimates and Forecasts 2020-2031
2.2 Global Biological Nematicides Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Biological Nematicides Sales Estimates and Forecasts 2020-2031
2.4 Global Biological Nematicides Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Biological Nematicides Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Biological Nematicides Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Biological Nematicides Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Microbial-based Nematicides Market Size by Manufacturers
4.5.2 Botanical Nematicides Market Size by Manufacturers
4.5.3 Biocontrol Agents Market Size by Manufacturers
4.5.4 Biostimulants Market Size by Manufacturers
4.5.5 Biofumigants Market Size by Manufacturers
4.5.6 Others Market Size by Manufacturers
4.6 Global Biological Nematicides Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Biological Nematicides Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Biological Nematicides Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Biological Nematicides Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Biological Nematicides Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Biological Nematicides Sales and Revenue by Type (2020-2031)
7.4 North America Biological Nematicides Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Biological Nematicides Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Biological Nematicides Sales and Revenue by Type (2020-2031)
8.4 Europe Biological Nematicides Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Biological Nematicides Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Biological Nematicides Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Biological Nematicides Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Biological Nematicides Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Biological Nematicides Sales and Revenue by Type (2020-2031)
10.4 Central and South America Biological Nematicides Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Biological Nematicides Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Biological Nematicides Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Biological Nematicides Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Biological Nematicides Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Bayer AG
12.1.1 Bayer AG Corporation Information
12.1.2 Bayer AG Business Overview
12.1.3 Bayer AG Biological Nematicides Product Models, Descriptions and Specifications
12.1.4 Bayer AG Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Bayer AG Biological Nematicides Sales by Product in 2024
12.1.6 Bayer AG Biological Nematicides Sales by Application in 2024
12.1.7 Bayer AG Biological Nematicides Sales by Geographic Area in 2024
12.1.8 Bayer AG Biological Nematicides SWOT Analysis
12.1.9 Bayer AG Recent Developments
12.2 Syngenta Crop Protection AG
12.2.1 Syngenta Crop Protection AG Corporation Information
12.2.2 Syngenta Crop Protection AG Business Overview
12.2.3 Syngenta Crop Protection AG Biological Nematicides Product Models, Descriptions and Specifications
12.2.4 Syngenta Crop Protection AG Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Syngenta Crop Protection AG Biological Nematicides Sales by Product in 2024
12.2.6 Syngenta Crop Protection AG Biological Nematicides Sales by Application in 2024
12.2.7 Syngenta Crop Protection AG Biological Nematicides Sales by Geographic Area in 2024
12.2.8 Syngenta Crop Protection AG Biological Nematicides SWOT Analysis
12.2.9 Syngenta Crop Protection AG Recent Developments
12.3 Corteva Agriscience
12.3.1 Corteva Agriscience Corporation Information
12.3.2 Corteva Agriscience Business Overview
12.3.3 Corteva Agriscience Biological Nematicides Product Models, Descriptions and Specifications
12.3.4 Corteva Agriscience Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Corteva Agriscience Biological Nematicides Sales by Product in 2024
12.3.6 Corteva Agriscience Biological Nematicides Sales by Application in 2024
12.3.7 Corteva Agriscience Biological Nematicides Sales by Geographic Area in 2024
12.3.8 Corteva Agriscience Biological Nematicides SWOT Analysis
12.3.9 Corteva Agriscience Recent Developments
12.4 BASF SE
12.4.1 BASF SE Corporation Information
12.4.2 BASF SE Business Overview
12.4.3 BASF SE Biological Nematicides Product Models, Descriptions and Specifications
12.4.4 BASF SE Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 BASF SE Biological Nematicides Sales by Product in 2024
12.4.6 BASF SE Biological Nematicides Sales by Application in 2024
12.4.7 BASF SE Biological Nematicides Sales by Geographic Area in 2024
12.4.8 BASF SE Biological Nematicides SWOT Analysis
12.4.9 BASF SE Recent Developments
12.5 Adama Agricultural Solutions
12.5.1 Adama Agricultural Solutions Corporation Information
12.5.2 Adama Agricultural Solutions Business Overview
12.5.3 Adama Agricultural Solutions Biological Nematicides Product Models, Descriptions and Specifications
12.5.4 Adama Agricultural Solutions Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Adama Agricultural Solutions Biological Nematicides Sales by Product in 2024
12.5.6 Adama Agricultural Solutions Biological Nematicides Sales by Application in 2024
12.5.7 Adama Agricultural Solutions Biological Nematicides Sales by Geographic Area in 2024
12.5.8 Adama Agricultural Solutions Biological Nematicides SWOT Analysis
12.5.9 Adama Agricultural Solutions Recent Developments
12.6 FMC Corporation
12.6.1 FMC Corporation Corporation Information
12.6.2 FMC Corporation Business Overview
12.6.3 FMC Corporation Biological Nematicides Product Models, Descriptions and Specifications
12.6.4 FMC Corporation Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 FMC Corporation Recent Developments
12.7 Nufarm
12.7.1 Nufarm Corporation Information
12.7.2 Nufarm Business Overview
12.7.3 Nufarm Biological Nematicides Product Models, Descriptions and Specifications
12.7.4 Nufarm Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Nufarm Recent Developments
12.8 Isagro Group
12.8.1 Isagro Group Corporation Information
12.8.2 Isagro Group Business Overview
12.8.3 Isagro Group Biological Nematicides Product Models, Descriptions and Specifications
12.8.4 Isagro Group Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Isagro Group Recent Developments
12.9 Certis USA
12.9.1 Certis USA Corporation Information
12.9.2 Certis USA Business Overview
12.9.3 Certis USA Biological Nematicides Product Models, Descriptions and Specifications
12.9.4 Certis USA Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Certis USA Recent Developments
12.10 Marrone Bio Innovations
12.10.1 Marrone Bio Innovations Corporation Information
12.10.2 Marrone Bio Innovations Business Overview
12.10.3 Marrone Bio Innovations Biological Nematicides Product Models, Descriptions and Specifications
12.10.4 Marrone Bio Innovations Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Marrone Bio Innovations Recent Developments
12.11 BioWorks Inc.
12.11.1 BioWorks Inc. Corporation Information
12.11.2 BioWorks Inc. Business Overview
12.11.3 BioWorks Inc. Biological Nematicides Product Models, Descriptions and Specifications
12.11.4 BioWorks Inc. Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 BioWorks Inc. Recent Developments
12.12 Valent BioSciences
12.12.1 Valent BioSciences Corporation Information
12.12.2 Valent BioSciences Business Overview
12.12.3 Valent BioSciences Biological Nematicides Product Models, Descriptions and Specifications
12.12.4 Valent BioSciences Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Valent BioSciences Recent Developments
12.13 Koppert B.V.
12.13.1 Koppert B.V. Corporation Information
12.13.2 Koppert B.V. Business Overview
12.13.3 Koppert B.V. Biological Nematicides Product Models, Descriptions and Specifications
12.13.4 Koppert B.V. Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Koppert B.V. Recent Developments
12.14 AgBiome, Inc.
12.14.1 AgBiome, Inc. Corporation Information
12.14.2 AgBiome, Inc. Business Overview
12.14.3 AgBiome, Inc. Biological Nematicides Product Models, Descriptions and Specifications
12.14.4 AgBiome, Inc. Biological Nematicides Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 AgBiome, Inc. Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Biological Nematicides Industry Chain
13.2 Biological Nematicides Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Biological Nematicides Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Biological Nematicides Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Biological Nematicides Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Biological Nematicides Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Biological Nematicides was estimated to be worth US$ 2377 million in 2025 and is projected to reach US$ 4018 million, growing at a CAGR of 7.9% from 2026 to 2032.
Published Date: 2026-07-14
Pages: 137
USD 3950.00
(Single User License)
The global Biological Nematicides market was valued at US$ 2377 million in 2025 and is anticipated to reach US$ 4018 million by 2032, at a CAGR of 7.9% from 2026 to 2032.
Published Date: 2026-04-21
Pages: 136
USD 2900.00
(Single User License)
The global market for Biological Nematicides was estimated to be worth US$ 2219 million in 2024 and is forecast to a readjusted size of US$ 3751 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 112
USD 3950.00
(Single User License)
The global market for Biological Nematicides was valued at US$ 2219 million in the year 2024 and is projected to reach a revised size of US$ 3751 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Published Date: 2025-02-15
Pages: 96
USD 2900.00
(Single User License)
The global Biological Nematicides market size was US$ 2219 million in 2024 and is forecast to a readjusted size of US$ 3751 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 100
USD 4250.00
(Single User License)
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published Date: 2024-04-08
Pages: 109
USD 4900.00
(Single User License)
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published Date: 2024-02-19
Pages: 125
USD 3950.00
(Single User License)
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published Date: 2024-02-07
Pages: 99
USD 2900.00
(Single User License)
The global market for Biological Nematicides was estimated to be worth US$ 2377 million in 2025 and is projected to reach US$ 4018 million, growing at a CAGR of 7.9% from 2026 to 2032.
Published: 2026-07-14
Pages: 137
The global Biological Nematicides market was valued at US$ 2377 million in 2025 and is anticipated to reach US$ 4018 million by 2032, at a CAGR of 7.9% from 2026 to 2032.
Published: 2026-04-21
Pages: 136
The global market for Biological Nematicides was estimated to be worth US$ 2219 million in 2024 and is forecast to a readjusted size of US$ 3751 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 112
The global market for Biological Nematicides was valued at US$ 2219 million in the year 2024 and is projected to reach a revised size of US$ 3751 million by 2031, growing at a CAGR of 7.9% during the forecast period.
Published: 2025-02-15
Pages: 96
The global Biological Nematicides market size was US$ 2219 million in 2024 and is forecast to a readjusted size of US$ 3751 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 100
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published: 2024-04-08
Pages: 109
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published: 2024-02-19
Pages: 125
Biological nematicides are natural or organic substances derived from living organisms that are used to control nematode populations in agriculture. Nematodes are microscopic roundworms that can cause significant damage to crops by feeding on plant roots or transmitting plant diseases. Biological nematicides offer an alternative approach to synthetic chemical nematicides, providing environmentally friendly and sustainable solutions for managing nematode infestations.
Published: 2024-02-07
Pages: 99
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now